U.S. STEM CELL, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-08-01: Form 8-K; Period of report 2012-08-01; Description 8.01 Other Events; Details 8.01.
- 2012-06-26: Form 8-K; Period of report 2012-06-25; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2012-04-04: Form 8-K; Period of report 2012-03-30; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2012-03-23: Form 8-K; Period of report 2012-03-20; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-08-01 | 8-K | 2012-08-01 | 8.01 Other Events | 8.01 Over the past several months, I have been in active negotiations with several groups interested in helping us restart our FDA-approved clinical trials. | d29668.htm |
| 2012-06-26 | 8-K | 2012-06-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 25, 2012, the Board of Directors of the Company accepted the resignation of Bruce Carson as a member of the Board of Directors. | d29580.htm |
| 2012-04-04 | 8-K | 2012-03-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d29331.htm |
| 2012-03-23 | 8-K | 2012-03-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 20, 2012, Bioheart, Inc. (the “Company”) terminated the employment of Catherine Sulawske-Guck, its Chief Operating Officer. | d29301_8-k.htm |
| 2012-01-30 | 8-K | 2012-01-24 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On January 24, 2012, Bioheart, Inc. (the “Company”) advised RBSM LLP of its decision to replace RBSM LLP as the Company’s independent registered public accounting firm. | d29106.htm |
| 2012-01-13 | 8-K | 2012-01-13 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 As disclosed in the Quarterly Report on Form 10-Q of Bioheart, Inc. (the “Company”) filed with the Securities and Exchange Commission on November 14, 2011, BlueCrest Venture Finance Master Fund Limited (“BlueCrest”) agreed with the Company and Greystone Capital (“Greystone”) on September 1, 2011, to split the note evidencing the BlueCrest Loan originated May 31, 2007 into two notes aggregating the outstanding principal balance, with the new note being in the principal amount of $139,729.82 (the “New Note”). | d29048_8k.htm |